CHINA PHARMA HOLDINGS, INC. Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount of $795.77 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2026-04-01
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2025 was $795.77K, a 32.74% decline from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2024 was $1.18M, a 54.39% increase from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2023 was $766.32K, a 20.61% decline from fiscal 2022.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2022 was $965.30K, a 14.72% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 12 month |
|---|---|
| 2025-12-31 | $795.77K 10-K · filed 2026-04-01 |
| 2024-12-31 | $1.18M 10-K · filed 2026-04-01 |
| 2023-12-31 | $766.32K 10-K · filed 2025-03-31 |
| 2022-12-31 | $965.30K 10-K · filed 2024-04-01 |
| 2021-12-31 | $841.43K 10-K · filed 2023-03-30 |
| 2020-12-31 | $708.50K 10-K · filed 2022-03-30 |
| 2019-12-31 | $5.17M 10-K · filed 2021-03-26 |
| 2018-12-31 | $2.78M 10-K · filed 2020-03-30 |
| 2017-12-31 | $4.90M 10-K · filed 2019-03-28 |
| 2016-12-31 | $9.78M 10-K · filed 2018-04-02 |
| 2015-12-31 | $2.41M 10-K · filed 2017-03-31 |
| 2012-12-31 | $160.30K 10-K · filed 2013-03-14 |
| 2011-12-31 | -$166.20K 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |